AD-214

N/A

Report date: 2024/07/05 11:20:34

Base Information

Drug NameAD-214
Drug Alias NameAD-214
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsLung Diseases, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdalta Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdalta Ltd
Inactive CompaniesN/A
Active IndicationsLung Diseases, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A